98%
921
2 minutes
20
Sudan virus (SUDV) causes highly lethal outbreaks of hemorrhagic disease throughout Africa, but there has yet to be an approved vaccine or therapeutic to combat this public health threat. The most common route of natural exposure to filoviruses is through mucosal contact which greatly impacts initial viral replication. Historically, SUDV animal models used an intramuscular infection route. Here, we sought to further characterize an animal model using mucosal challenge routes and compared the impact that intramuscular, intranasal, or aerosol exposure had on SUDV pathogenicity in a ferret model. We determined that the route of infection did not significantly impact overall SUDV pathogenicity; only subtle changes were detected in magnitude of viremia and oral viral shedding. Additionally, we sought to determine if preexisting Lloviu virus (LLOV) immunity could protect ferrets from lethal SUDV infection. We found that the previous immunity elicited by LLOV infection was not sufficient to protect ferrets from lethal SUDV disease. In conclusion, our results indicate that the infection route has minimal effect on overall pathogenicity of SUDV in ferrets and that prior LLOV infection does not elicit a cross-protective immune response to SUDV.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/bs.aivir.2025.03.007 | DOI Listing |
Phytochemistry
September 2025
HUN-REN-USZ Biologically Active Natural Products Research Group, University of Szeged, Eötvös Str. 6, 6720, Szeged, Hungary; Department of Pharmacognosy, University of Szeged, Eötvös Str. 6, 6720, Szeged, Hungary. Electronic address:
Previously undescribed steroids vernomigeodiins A-D (1-4), were isolated from the African medicinal plant Vernoniastrum migeodii along with known sterols 5-10 and the tripeptide aurantiamide acetate (11). The isolated steroids featured a stigmastane skeleton with a unique conjugated Δ-diene segment and a highly oxidized side chain, occasionally forming a bi- or tricyclic ring system. Sterols 1-3, 5-9 are glucosylated, whereas 4 and 10 are aglycons.
View Article and Find Full Text PDFEBioMedicine
September 2025
Albert B. Sabin Vaccine Institute, 2000 Pennsylvania Ave, NW, Suite 7000, Washington, DC, 20006, USA. Electronic address:
Background: Sudan virus and Marburg virus are high priority biological threat pathogens with fatality rates of 25-90%. Recent outbreaks in Uganda, Equatorial Guinea, and Rwanda between 2022 and 2025 emphasise the critical need for effective vaccines. The aim of this phase 1b study was to determine clinical safety, tolerability, and immunogenicity of these monovalent vaccines.
View Article and Find Full Text PDFVaccine
September 2025
Department of Tropical Medicine, Medical Microbiology & Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA. Electronic address:
Filoviruses, including the well-known Ebola virus, are among the most lethal pathogens known. The current vaccine landscape is constrained by stringent cold chain requirements making vaccine deployment challenging, especially in regions with limited infrastructure. ERVEBO®, the sole FDA-approved filovirus vaccine, requires ultra-cold storage.
View Article and Find Full Text PDFAnn Med Surg (Lond)
September 2025
Department of Research, Toufik's World Organization, Sumy, Ukraine.
In 2022, the presumption of monkeypox (mpox) to be of limited epidemiology shifted when a global outbreak was announced. Being a member of the Orthopoxvirus genus in the Poxviridae family, it'd been reported in over 82 countries with over 17 000 confirmed cases by July 2022, thus showing its capability for spreading rapidly. As the smallpox vaccine offers 85% cross-immunity against mpox, the outbreak highlighted the attenuation of global immunity against orthopoxviruses after the cessation of vaccination campaigns against smallpox.
View Article and Find Full Text PDFElife
September 2025
Department of Biochemistry & Biophysics and Bioengineering, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Cryptic pockets are of growing interest as potential drug targets, particularly to control protein-nucleic acid interactions that often occur via flat surfaces. However, it remains unclear whether cryptic pockets contribute to protein function or if they are merely happenstantial features that can easily be evolved away to achieve drug resistance. Here, we explore whether a cryptic pocket in the Interferon Inhibitory Domain (IID) of viral protein 35 (VP35) of Zaire ebolavirus aids its ability to bind double-stranded RNA (dsRNA).
View Article and Find Full Text PDF